We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current PTCT market cap is 2.23B. The company's latest EPS is USD -8.1794 and P/E is -3.55.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 222.43M | 167.41M | 220.38M | 340.31M | 195.08M |
Operating Income | -68.19M | -194.04M | -117.62M | -211.94M | -118.16M |
Net Income | -109.32M | -170.89M | -138.96M | -198.88M | -132.97M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 306.98M | 380.77M | 538.59M | 698.8M | 1.07B |
Operating Income | -241.16M | -431.77M | -374.94M | -473.31M | -439.5M |
Net Income | -251.58M | -438.16M | -523.9M | -559.02M | -626.6M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 1.58B | 1.71B | 1.61B | 1.34B | 1.26B |
Total Liabilities | 1.8B | 2.05B | 2.07B | 1.92B | 1.93B |
Total Equity | -226.9M | -347.09M | -457.56M | -579.27M | -670.81M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 1.62B | 2.21B | 1.94B | 1.71B | 1.9B |
Total Liabilities | 1.03B | 1.73B | 1.94B | 2.05B | 2.71B |
Total Equity | 594.33M | 481.98M | 1.44M | -347.09M | -818.56M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -190.69M | -356.65M | -29.49M | -43.61M | -58.13M |
Investing | 257.74M | 290.18M | -28.97M | -52.72M | -82.32M |
Financing | -134.97M | 167.95M | 4.09M | 22.55M | 25.92M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -98.64M | -194.07M | -251.33M | -356.65M | -158.42M |
Investing | -387.24M | -561.55M | 219.18M | 290.18M | -176.74M |
Financing | 613.21M | 668.72M | 20.88M | 167.95M | 646.4M |
Market Cap | 2.23B |
Price to Earnings Ratio | -3.55 |
Price to Sales Ratio | 2.09 |
Price to Cash Ratio | 3.75 |
Price to Book Ratio | -2.72 |
Dividend Yield | - |
Shares Outstanding | 76.61M |
Average Volume (1 week) | 518.53k |
Average Volume (1 Month) | 897.76k |
52 Week Change | -36.40% |
52 Week High | 59.84 |
52 Week Low | 17.53 |
Spread (Intraday) | 1.53 (5.09%) |
Company Name | PTC Therapeutics Inc |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://www.ptcbio.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions